References

Abrahamsson, A., H. O. Adami, A. Taube, K. Kim, M. Zelen, and M. Kulldorff. 1996. Re: Long-term survival and mortality in prostate cancer treated with noncurative intent [letter; comment]. J Urol 155 (1):296-298.

Anderson, T. J., J. Lamb, P. Donnan, F. E. Alexander, A. Huggins, and et al. 1991. Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer 64 (1):108-113.

Andersson, I. 1984. Breast cancer screening in Malm. Recent Results Cancer Res 90:114-116.

Andersson, I., K. Aspegren, L. Janzon, T. Landberg, K. Lindholm, and et al. 1988. Mammographic screening and mortality from breast cancer: the Malm mammographic screening trial. BMJ 297:943-948.

Aristizabal, N., C. Cuello, P. Correa, T. Collazos, and W. Haenszal. 1984. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. International J. of Cancer 34:5-9.

Aus, G., J. Hugosson, and L. Norlen. 1995. Long-term survival and mortality in prostate cancer treated with noncurative intent [see comments]. J Urol 154 (2 Pt 1):460-465.

Baines, C. J. 1994. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 120:326-334.

Baines, C. J., and A. B. Miller. 1997. Mammography versus clinical examination of the breasts. Monogr Natl Cancer Inst (22):125-129.

Baldauf, J. J., M. Dreyfus, J. Ritter, P. Meyer, and E. Philippe. 1997. Cervicography. Does it improve cervical cancer screening? Acta Cytol 41 (2):295-301.

BCDDP. 1979. Report of the Working Group to Review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 62 (3):639-709.

Bedell, M. B., M. E. Wood, D. C. Lezotte, S. M. Sedlacek, and M. M. Orleans. 1995. Delay in diagnosis and treatment of breast cancer: implications for education. J Cancer Educ 10 (4):223-228.

Beemsterboer, P. M. M. 1999. Evaluation of screening programmes. Studies on breast cancer and prostate cancer [dissertation], Department of Public Health, Erasmus University Rotterdam, Rotterdam.

Beemsterboer, P. M. M., H. J. de Koning, P. G. Warmerdam, R. Boer, E. Swart, Dierks M.L., and et al. 1994. Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer 58:623-628.

Berget, A. 1979. Influence of population screening on morbidity and mortality of cancer of the uterine Cervix in Maribo Amt. Dan Med Bull 26 (2):91-100.

Berrino, F. 1993. Personal communication on screening exposure and the DPCP.

Berrino, F., G. Gatta, M. D'Alto, P. Crosignani, and E. Riboli. 1984. Use of case-control studies in evaluation of screening programmes. UICC Technol Rep Ser 78:24-43.

Bhargava, V. L., K. Verma, R. Sharma, S. Batra, and P. N. Anandalakshmy. 1993. A hospital-based study on the use of paramedical personnel for clinical downstaging of cancer cervix. Indian J Med Res 98:65-68.

Black, R. J., F. Bray, J. Ferlay, and D. M. Parkin. 1997. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990 [see comments] [published erratum appears in Eur J Cancer 1997 Dec;33(14):2440]. Eur J Cancer 33 (7):1075-1107.

Blanks, R. G., S. M. Moss, and M. G. Wallis. 1996. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme. J Med Screen 3 (4):200-203.

Blettner, M., W. Sauerbrei, B. Schlehofer, T. Scheuchenpflug, and C. Friedenreich. 1999. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28 (1):1-9.

Boer, R., H. J. de Koning, P. M. M. Beemsterboer, P. G. Warmerdam, and F. H. Schrder. 1997. A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer. J Urol 157 (5):1768-1771; discussion 1771-1772.

Boer, R., H.J. de Koning, A. Threfall, P. Warmerdam, A. Street, and et al. 1998. Cost-effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study [see comments]. BMJ 317 (7155):376-379.

Boer, R., H. J. de Koning, G. J. van van Oortmarssen, and P.J. van der Maas. 1995. In search of the best upper age limit for breast cancer screening. Eur J Cancer 31A (12):2040-2043.

Boer, R., G. J. van Oortmarssen, and H.J. de Koning. 1995. Cost-effectiveness of mammography screening.(letter + reply Rosenquist and Lindfors). JAMA 275 (2):111-112.

Boer, R., P. Warmerdam, and H.J. de Koning. 1994. Extra incidence caused by mammographic screening [letter]. Lancet 343:979.

Boyes, D. A., B. Morrison, E. G. Knox, G. J. Draper, and A. B. Miller. 1982. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 5:1-29.

Brekelmans, C. T., J. M. van Gorp, P. H. Peeters, and H. J. Collette. 1996. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer 78 (6):1220-1228.

Brown, B. W., C. Brauner, and M. C. Minnotte. 1993. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 85 (12):979-987.

Brown, M. L., and L. Fintor. 1993. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Research Treat 25 (2):113-118.

Burns, P. E. 1978. False-negative mammograms delay diagnosis of breast cancer. N Engl J Med 299 (4):201-202.

Cairns, J. A., and M. M. van der Pol. 1997. Saving future lives. A comparison of three discounting models. Health Econ 6 (4):341-350.

Cantor, S. B. 1994. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making 14 (3):259-265.

Caplan, L. S., and K. J. Helzlsouer. 1992. Delay in breast cancer: a review of the literature. Public Health Rev 20 (3-4):187-214.

Caplan, L. S., K. J. Helzlsouer, S. Shapiro, M. N. Wesley, and B. K. Edwards. 1996. Reasons for delay in breast cancer diagnosis. Prev Med 25 (2):218-224.

CBS. 1992. Life tables, 1991 and 1987-1991. Mndstat Bevolk (CBS) 11 (12):41-44.

CBS. 1996. Male deaths by cause of death and age and average male population, 1994. Mndstat Bevolk (CBS) 15 (2):28-29.

Celentano, D. D., A. C. Klassen, C. S. Weisman, and N. B. Rosenshein. 1988. Cervical cancer screening practices among older women: results from the Maryland Cervical Cancer Case-Control Study. J Clin Epidemiol 41 (6):531-541.

Chamberlain, J. 1993. Firmer evidence on the value of breast screening - the Swedish overview. Eur J Cancer 29A (13):1804-1805.

Chamberlain, J., S. M. Moss, A. E. Kirkpatrick, M. Michell, and L. Johns. 1993. National Health Service breast screening programme results for 1991-2. [publisched erratum appears in BMJ 1993;307:543, see comments BMJ 1993;307:353-356]. BMJ 307:353-356.

Chang, H. R., B. Cole, and K. I. Bland. 1997. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography. Monogr Natl Cancer Inst (22):145-149.

Chen, H. H., S. W. Duffy, L. Tabr, and N. E. Day. 1997. Markov chain models for progression of breast cancer. Part II: prediction of outcomes for different screening regimes. J Epidemiol Biostat 2 (1):25-35.

Chessa, A.G., M.E. van den Akker-van Marle, G.J. van Oortmarssen, R. Boer, M. van Ballegooijen, and J.D.F. Habbema. submitted. Uncertainty analysis of the const-effectiveness of cervical cancer screening policies using the Miscan microsimulation program. .

Chodak, G. W., R. A. Thisted, G. S. Gerber, J. E. Johansson, J. Adolfsson, and et al. 1994. Results of conservative management of clinically localized prostate cancer. N Engl J Med 330 (4):242-248.

Clarke, E. A., and T. W. Anderson. 1979. Does screening by "Pap" smears help prevent cervical cancer? Lancet 2 (8132):1-4.

Collette, H. J. A., J. J. Rombach, N. E. Day, and F. de Waard. 1984. Evaluation of screening for breast cancer in a non-randomised study (The DOM Project) by means of a case-control study. Lancet 1 (8388):1224-1226.

Costanza, M. E. 1992. Breast cancer screening in older women. Cancer 69 (7 Supp):1925-1931.

Cox, B. 1997. Variation in the effectiveness of breast screening by year of follow-up. Monogr Natl Cancer Inst (22):69-72.

Cox, D.C., and P. Baybutt. 1981. Methods for uncertainty analysis: a comparitive survey. Risk Analysis 1:251-258.

Cronin, K. A., D. L. Weed, R. J. Connor, and P. C. Prorok. 1998. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 90 (7):498-504.

Davey Smith, G., and M. Egger. 1998. Meta-analysis. Unresolved issues and future developments. Bmj 316 (7126):221-225.

Davey Smith, G., M. Egger, and A. N. Phillips. 1997. Meta-analysis. Beyond the grand mean? BMJ 315 (7122):1610-1614.

Day, N.E., S.D. Walter, L. Tabr, C.J.G. Fagerberg, and H.J.A. Collette. 1988. The sensitivity and lead time of breast cancer screening: a comparison of the results of different studies. In Screening for breast cancer, edited by N. E. Day and A. B. Miller. Toronto: Hans Huber Publishers.

de Haes, J, C.J.M., H. J. de Koning, G. J. van Oortmarssen, H. M. E. van Agt, A. E. de Bruyn, and P. J. van der Maas. 1991. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 49:538-544.

de Koning, H.J. 1993. The effects and costs of breast cancer screening [dissertation], Erasmus University Rotterdam, Rotterdam.

de Koning, H. J., R. Boer, P. G. Warmerdam, P. M. M. Beemsterboer, and P. J. van der Maas. 1995a. Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 87 (16):1217-1223.

de Koning, H. J., J. Fracheboud, R. Boer, A. L. Verbeek, H. J. Collette, J. H. Hendriks, B. M. van Ineveld, A. E. de Bruyn, and P. J. van der Maas. 1995b. Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer 60 (6):777-780.

de Koning, H.J., J. A. van Dongen, and P.J. van der Maas. 1994. Changes in use of breast-conserving therapy in years 1987-2000. Br J Cancer 70:1165-1170.

de Koning, H. J., B. M. van Ineveld, G. J. van Oortmarssen, J.C.J.M. de Haes, H. J. A. Collette, and et al. 1991. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49:531-537.

De Sutter, Ph, M. Coibion, M. Vosse, D. Hertens, F. Huet, F. Wesling, M. Wayembergh, C. Bourdon, and Ph Autier. 1998. A multicentre study comparing cervicography and cytology in the detection of cervical intraepithelial neoplasia. Br J Obstet Gynaecol 105 (6):613-620.

Drummond, M.F., B. O'Brien, G.L. Stoddart, and G.W. Torrance. 1997. Methods for the economic evaluation of health care programmes [second edition]. Oxford: Oxford University Press.

Duffy, S. W., L. Tabr, G. Fagerberg, A. Gad, O. Grntoft, and et al. 1991. Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer 64:1133-1138.

Eastman, P. 1997. NCI adopts new mammography screening guidelines for women [news]. J Natl Cancer Inst 89 (8):538-540.

Ebeling, K., and P. Nischan. 1987. Screening for lung cancer--results from a case-control study. Int J Cancer 40 (2):141-144.

Eckhardt, S., F. Badellino, and G. P. Murphy. 1994. UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September - 1 October 1993. Int J Cancer 56:1-5.

Eddy, D. M. 1990. Screening for cervical cancer [see comments]. Ann Intern Med 113 (3):214-226.

Ederer, F., L.M. Axtell, and S.J. Cutler. 1961. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101-121.

Efron, B., and R. Tibshirani. 1993. An introduction to the bootstrap. New York: Chapman & Hall.

Ekelund, RB, and RD Tollison. 1986. Economics. Boston: Little, Brown and Company.

Elwood, J. M., B. Cox, and A. K. Richardson. 1993. The effectiveness of breast cancer screening by mammography in younger women [published errata appear in Online J Curr Clin Trials 1993 Mar 5;Doc No 34:[295 words; 2 paragraphs] and 1994 Mar 31;Doc No 121:[385 words; 4 paragraphs]] [see comments]. Online J Curr Clin Trials Doc No 32:[23,227 words; 195 paragraphs].

Elwood, J. M., and W. P. Moorehead. 1980. Delay in diagnosis and long-term survival in breast cancer. Br Med J 280:1291-1294.

Estve, J., E. Benhamou, and L. Raymond. 1994. Statistical methods in cancer research. Vol. VI. Lyon: WHO/IARC.

Fagerberg, G., L. Baldetorp, O. Grontoft, B. Lundstrom, J. C. Manson, and B. Nordenskjold. 1985. Effects of repeated mammographic screening on breast cancer stage distribution: Results from a randomised study of 92 934 women in a Swedish county. Acta Radiol 24 (6):465-473.

Feig, S. A., and R. E. Hendrick. 1997. Radiation risk from screening mammography of women aged 40-49 years. Monogr Natl Cancer Inst (22):119-124.

Feuer, E. J., R. M. Merrill, and B. J. Hankey. 1999. Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 91 (12):1025-1032.

Fletcher, S. W. 1997. Breast cancer screening among women in their forties: an overview of the issues. Monogr Natl Cancer Inst (22):5-9.

Fletcher, S. W., W. Black, R. Harris, B. K. Rimer, and S. Shapiro. 1993a. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85 (20):1644-1656.

Fletcher, S. W., W. Black, R. Harris, B. K. Rimer, and S. Shapiro. 1993b. Report of the International Workshop on Screening for Breast Cancer [see comments]. J Natl Cancer Inst 85 (20):1644-1656.

Forrest, A. P., and F. E. Alexander. 1995. A question that will not go away: at what age shoud mammographic screening begin? J Natl Cancer Inst 87 (16):1195-1199.

Forrest, A.P.M. 1987. Report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a Working Group chaired by Sir Patrick Forrest. London: Her Majesties Stationary Office.

Forrest, A. P. M., and R. J. Aitken. 1990. Mammography screening for breast cancer. Annu Rev Med 41:117-132.

Forrest, P. 1986. Breast cancer screening. Report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a working group chaired by Prof. Sir Patrick Forrest. London: Her Majesty's Stationery Office.

Fracheboud, J., R. Boer, B. M. van Ineveld, P. M. M. Beemsterboer, A. L. M. Verbeek, and et al. 1997. Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nederland - VI, Het zesde evaluatie-rapport. Edited by R. Erasmus Universiteit, U. Universiteit and N. Kath. universiteit. Rotterdam: Letb.

Frankel, S. D., E. A. Sickles, B. N. Curpen, R. A. Sollitto, S. H. Ominsky, and H. B. Galvin. 1995. Initial versus subsequent screening mammography: comparison of findings and their prognostic significance. AJR Am J Roentgenol 164 (5):1107-1109.

Friedman, G. D., R. A. Hiatt, Quesenberry Cp, Jr., J. V. Selby, and N. S. Weiss. 1995. Problems in assessing screening experience in observational studies of screening efficacy: example of urinalysis screening for bladder cancer. J Med Screen 2 (4):219-223.

Frisch, L. E., F. H. Milner, and D. G. Ferris. 1994. Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening [see comments]. J Fam Pract 39 (5):457-460.

Frischbier, H.J., B.P. Robra, W. Hoeffken, and M.L. Dierks. 1994. Mammographie in der Krebsfrueherkennung. Stuttgart: Ferdinand Enke Verlag.

Frisell, J., G. Eklund, L. Hellstrm, U. Glas, and A. Somell. 1989. The Stockholm breast cancer screening trial - 5 year results and stage at discovery. Breast Cancer Res Treat 13:79-87.

Frisell, J., U. Glas, L. Hellstrm, and A. Somell. 1986. Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat 8:45-54.

Gaffikin, L., P.D. Blumenthal, J. McGrath, and Z.M. Chirenje. 1999. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 353 (9156):869-873.

George, N. J. R. 1988. Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet i:494-497.

Gill, T. M., and R. I. Horwitz. 1995. Evaluating the efficacy of cancer screening: clinical distinctions and case-control studies [see comments]. J Clin Epidemiol 48 (2):281-292.

Glasziou, P., and L. Irwig. 1997. The quality and interpretation of mammographic screening trials for women ages 40-49. Monogr Natl Cancer Inst (22):73-77.

Gtzsche, P. C., and O. Olsen. 2000. Is screening for breast cancer with mammography justifiable? Lancet 355 (9198):129-134.

Grnberg, H. 1995. Prostate cancer, epidemiological studies [dissertation], Umea University, Umea.

Gullberg, B., I. Andersson, L. Janzon, and J. Ranstam. 1991. Screening mammography. Lancet 337:244.

Gustafsson, L., J. Ponten, R. Bergstrom, and H. O. Adami. 1997. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 71 (2):159-165.

Habbema, J. D.F., S. J. de Vlas, A. P. Plaisier, and G. J. van Oortmarssen. 1996. The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. Am J Trop Med Hyg 55 (5 Suppl):165-169.

Habbema, J. D.F., J.Th.N. Lubbe, G. J. van Oortmarssen, and P. J. van der Maas. 1987. A simulation approach to cost-effectiveness and cost-benefit calculations of screening for the early detection of disease. Eur J Oper Res 29:159-166.

Habbema, J. D.F., G. J. van Oortmarssen, J.Th.N. Lubbe, and P. J. van der Maas. 1985. The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 20 (1):79-93.

Habbema, J. D.F., G. J. van Oortmarssen, D. J. van Putten, J. T. Lubbe, and P.J. van der Maas. 1986. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York Study. J Natl Cancer Inst 77 (2):317-320.

Hakama, M., K. Holli, J. Isola, O. P. Kallioniemi, A. Krkkinen, and et al. 1995. Aggressiveness of screen-detected breast cancers. Lancet 345:221-224.

Harris, R. 1997. Variation of benefits and harms of breast cancer screening with age. Monogr Natl Cancer Inst (22):139-143.

Hosek, R. S., W. D. Flanders, and A. J. Sasco. 1996. Bias in case-control studies of screening effectiveness. Am J Epidemiol 143 (2):193-201.

Isaacs, D., and D. Fitzgerald. 1999. Seven alternatives to evidence based medicine. BMJ 319 (7225):1618.

Johansson, J. E., H. O. Adami, S. O. Andersson, R. Bergstrm, L. Holmberg, and U. B. Krusemo. 1992. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267 (16):2191-2196.

Kaplan, E.L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.

Koopmanschap, M.A. 1994. Complementary analyses in economic evaluation of health care [dissertation], Erasmus University Rotterdam, Rotterdam.

Koopmanschap, M. A., G. J. van Oortmarssen, H. M.E. van Agt, M. van Ballegooijen, J. D.F. Habbema, and J.Th.N. Lubbe. 1990. Cervical-cancer screening: attendance and cost-effectiveness. Int J Cancer 45 (3):410-415.

Kopans, D. B. 1997a. Canadian National Breast Screening Study [letter]. Lancet 350 (9080):810-810.

Kopans, D. B. 1997b. NBSS: opportunity to compromise the process. CMAJ 157 (3):247-248.

Kopans, D. B. 1997c. An overview of the breast cancer screening controversy. Monogr Natl Cancer Inst (22):1-3.

Libstug, A. R., V. Moravan, and S. E. Aitken. 1998. Results from the Ontario breast screening program, 1990-1995. J Med Screen 5 (2):73-80.

Loeve, F., R. Boer, G. J. van Oortmarssen, M. van Ballegooijen, and J. D.F. Habbema. 1999. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 32:13-33.

MacGregor, J. E., S. M. Moss, D. M. Parkin, and N. E. Day. 1985. A case-control study of cervical cancer screening in north east Scotland. BMJ 290:1543-1546.

McCann, J., S. Wait, B. Seradour, and N. Day. 1997. A comparison of the performance and impact of breast cancer screening programmes in East Anglia, U.K. and Bouches du Rhne, France. Eur J Cancer 33 (3):429-435.

Megevand, E., L. Denny, K. Dehaeck, R. Soeters, and B. Bloch. 1996. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstet Gynecol 88 (3):383-386.

Michaelson, J. S., E. Halpern, and D. B. Kopans. 1999. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology 212 (2):551-560.

Miller, A. B., C. J. Baines, T. To, and C. Wall. 1992. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 147 (10):1459-1476.

Miller, A. B., T. To, C. J. Baines, and C. Wall. 1997. The Canadian National Breast Screening Study: update on breast cancer mortality. Monogr Natl Cancer Inst (22):37-41.

Morgan, M.G., and M. Henrion. 1990. Uncertainty: A guide to dealing with uncertainty in quantitative risk and policy analysis. New York: Cambridge University Press.

Morrison, A. S. 1982. Case definition in case-control studies of the efficacy of screening. Am J Epidemiol 115 (1):6-8.

Moss, S. M. 1991. Case-control studies of screening. Int J Epidemiol 20 (1):1-6.

Nandakumar, A., N. Anantha, and T. C. Venugopal. 1995. Incidence, mortality and survival in cancer of the cervix in Bangalore, India. Br J Cancer 71 (6):1348-1352.

National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch,. 1997. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-1994), released May 1997, based on the August 1996 Submission. Bethesda, MD: National Cancer Institute.

Neave, L. M., B. H. Mason, and R. G. Kay. 1990. Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat 15 (2):103-108.

NeCaRe. 1991. Incidence of cancer in the Netherlands 1991. Utrecht: NeCaRe.

Nene, B. M., S. Deshpande, K. Jayant, A. M. Budukh, P. S. Dale, D. A. Deshpande, A. S. Chiwate, S. G. Malvi, S. Deokar, D. M. Parkin, and R. Sankaranarayanan. 1996. Early detection of cervical cancer by visual inspection: a population- based study in rural India. Int J Cancer 68 (6):770-773.

Nystrm, L, and L-G. Larsson. 1993. Re: Breast cancer screening with mammography [letter]. Lancet 341:1531-1532.

Nystrm, L., L. E. Rutqvist, S. Wall, A. Lindgren, M. Lindqvist, and et al. 1993. Breast cancer screening with mammography: overview of Swedish randomised trials. Published erratum appears in Lancet 1993 Nov 27;342(8883):1372. Lancet 341 (8851):973-978.

Oshima, A., N. Hirata, T. Ubukata, K. Umeda, and I. Fujimoto. 1986. Evaluation of a mass screening program for stomach cancer with a case- control study design. Int J Cancer 38 (6):829-833.

Otten, J. D., J. A. van Dijck, P. G. Peer, H. Straatman, A. L. Verbeek, and M. Mravunac. 1996. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 50 (3):353-358.

Paci, E., R. Boer, M. Zappa, H. J. de Koning, G. J. van Oortmarssen, E. Crocetti, and et al. 1995. A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. Eur J Cancer 31A (3):348-353.

Palli, D., M. Rosselli del Turco, E. Buiatti, S. Carli, S. Ciatto, and L. Toscani. 1986. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 38:501-504.

Parkin, D. M., C. S. Muir, S. L. Whelan, Y. T. Gao, J. Ferlay, and J. Powell. 1992. Cancer incidence in five continents. Vol. VI. Lyon: WHO/IARC.

Peer, P. G. M., J.A.A.M. van Dijck, J.H.C.L. Hendriks, R. Holland, and A. L. M. Verbeek. 1993. Age-dependent growth rate of primary breast cancer. Cancer 71 (11):3547-3551.

Peer, P. G. M., R. Holland, J.H.C.L. Hendriks, M. Mravunac, and A. L. M. Verbeek. 1994. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness [see comments]. J Natl Cancer Inst 86 (6):436-441.

Percy, C., V.V. Holten, and C. Muir. 1990. International classification of diseases for oncology [2nd edition]. Geneva: WHO.

Percy, C. L., B. A. Miller, and L. A. Gloeckler Ries. 1990. Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. Ann N Y Acad Sci 609:87-97; discussion 97-99.

Porta, M., M. Galln, N. Malats, and J. Planas. 1991. Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 45 (3):225-230.

Registrar General of India. 1995. SRS Based Abridged Life Tables 1988-92. Occasional Paper No.4 of 1995. New Delhi: Office of the Registrar General.

Richards, M. A., S. Braysher, W. M. Gregory, and R. D. Rubens. 1993. Advanced breast cancer: use of resources and cost implications. Br J Cancer 67 (4):856-860.

Roberts, M. M., F. E. Alexander, T. J. Anderson, U. Chetty, P. T. Donnan, and et al. 1990. Edinburgh trial of screensing for breast cancer: mortality at seven years. Lancet 335:241-246.

Russell, L. B., M. R. Gold, J. E. Siegel, N. Daniels, and M. C. Weinstein. 1996. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine [see comments]. JAMA 276 (14):1172-1177.

Salzmann, P., K. Kerlikowske, and K. Phillips. 1997. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 127 (11):955-965.

Sankaranarayanan, R., B. Shyamalakumary, R. Wesley, N. Sreedevi Amma, D. M. Parkin, and M. K. Nair. 1999. Visual inspection with acetic acid in the early detection of cervical cancer and precursors [letter]. Int J Cancer 80 (1):161-163.

Sankaranarayanan, R., R. Wesley, T. Somanathan, N. Dhakad, B. Shyamalakumary, and N. S. Amma. 1998. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 83 (10):2150-2156.

SAS. 1991. SAS/STAT Software: the PHREG Procedure, Version 6, Cary NC: SAS Institute Inc.

Sasco, A. J., N. E. Day, and S. D. Walter. 1986. Case-control studies for the evaluation of screening. J Chron Dis 39 (5):399-405.

Schrijvers, C. T., J. W. W. Coebergh, L. H. van der Heijden, and J. P. Mackenbach. 1995. Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer 75 (12):2946-2953.

Scottish Cancer Therapy Network. 1996. Scottish breast cancer audit 1987 and 1993. Report to the Chief Scientist and CRAG: Scottish Cancer Therapy Network.

Sehgal, A., V. Singh, S. Bhambhani, and U. K. Luthra. 1991. Screening for cervical cancer by direct inspection. Lancet 338 (8762):282.

Selby, J. V., G. D. Friedman, C. P. Quesenberry, Jr., and N. S. Weiss. 1992. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (10):653-657.

Shapiro, S., P. Strax, L. Venet, and W. Venet. 1974. Changes in 5-year breast cancer mortality in a breast cancer screening program. In Seventh National Cancer Conference Proceedings: American Cancer Society.

Shapiro, S., W. Venet, P. Strax, L. Venet, and R. Roeser. 1982. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69 (2):349-355.

Shapiro, S., W. Venet, P. Strax, L. Venet, and R. Roeser. 1985. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr 67:65-74.

Siegel, J. E., M. C. Weinstein, L. B. Russell, and M. R. Gold. 1996. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine [see comments]. JAMA 276 (16):1339-1341.

Singh, V., A. Sehgal, and U. K. Luthra. 1992. Screening for cervical cancer by direct inspection. BMJ 304:534-535.

Smith, R. A. 1995. Screening women aged 40-49 years: where are we today? J Natl Cancer Inst 87 (16):1198-1200.

Street, A.D., J. Posnett, A.G. Threlfall, C.B.J. Woodman, E. Twelves, E.H.I. Friedman, and et al. 1996. Economic evaluation of proposed changes to the breast screening programme. York: Health Economics Consortium: University of York.

Sujathan, K., S. Kannan, K. R. Pillai, A. Mathew, M. Joseph, B. Symalakumari, and M. K. Nair. 1995. Implications of gynaecological abnormalities in pre-selection criteria for cervical screening: preliminary evaluation of 3602 subjects in south India. Cytopathology 6 (2):75-87.

Tabr, L. 1996. Re: quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer screening trials.(letter + response Koning de, et al). J Natl Cancer Inst 88 (1):52-53.

Tabr, L., E. Akerlund, and A. Gad. 1984. Five-year experience with single-view mammography randomized controlled screening in Sweden. Recent Results Cancer Res 90:105-513.

Tabr, L., C. J. Fagerberg, A. Gad, L. Baldetorp, L. H. Holmberg, O. Grontoft, U. Ljungquist, B. Lundstrom, J. C. Manson, and G. Eklund. 1985. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-832.

Tabr, L., C.J.G. Fagerberg, and N.E. Day. 1988. Evaluation of the results. In Screening for breast cancer, edited by N. E. Day and A. B. Miller. Toronto: Hans Huber Publishers.

Tabr, L., G. Fagerberg, H. H. Chen, S. W. Duffy, C. R. Smart, and et al. 1995. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 75 (10):2507-2517.

Tabr, L., G. Fagerberg, N. E. Day, and L. Holmberg. 1987. What is the optimum interval between mammographic screening examinations?- An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55:547-551.

Tabr, L., G. Fagerberg, S. W. Duffy, and N. Day. 1989. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 43 (2):107-114.

Tabr, L., G. Fagerberg, S. W. Duffy, N. E. Day, A. Gad, and O. Grntoft. 1992. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30 (1):187-210.

Thurfjell, E. L., and J. A.. Lindgren. 1994. Population-based mammography screening in Swedish clinical practice: prevalence and incidence sreening in Uppsala County. Radiology 193 (2):351-357.

van Ballegooijen, M. 1998a. Comparing the predictions of a cervical cancer natural history model with incidence and mortality trends after the introduction of screening. In Effects and costs of cervical cancer screening [dissertation], edited by M. van Ballegooijen. Rotterdam: Erasmus Universiteit Rotterdam.

van Ballegooijen, M. 1998b. Effects and costs of cervical cancer screening [dissertation], Erasmus University Rotterdam, Rotterdam.

van Ballegooijen, M., J. D.F. Habbema, G. J. van Oortmarssen, M. A. Koopmanschap, J.Th.N. Lubbe, and H. M. E. van Agt. 1992a. Preventive pap-smears: balancing costs, risks and benefits. Br J Cancer 65:930-933.

van Ballegooijen, M., M. A. Koopmanschap, and J. D.F. Habbema. 1995. The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The Netherlands. Eur J Cancer 31A (10):1672-1676.

van Ballegooijen, M., M. A. Koopmanschap, A. J. Subandono, A. J. S. Tjokrowardojo, and G. J. van Oortmarssen. 1992b. Care and costs for advanced cervical cancer. Eur J Cancer 28A (10):1703-1708.

van Ballegooijen, M., M. A. Koopmanschap, G. J. van Oortmarssen, J. D.F. Habbema, J.Th.N. Lubbe, and H. M. van Agt. 1990. Diagnostic and treatment procedures induced by cervical cancer screening. Eur J Cancer 26 (9):941-945.

van Ballegooijen, M., M. E. van den Akker-van Marle, P. G. Warmerdam, C. J. Meijer, J. M. Walboomers, and J. D.F Habbema. 1997. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness. Br J Cancer 76 (5):651-657.

van den Akker-van Marle, M. E., C. M. Reep-van den Bergh, R. Boer, A. Del Moral, N. Ascunce, and H. J. de Koning. 1997. Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round. Int J Cancer 73 (4):464-469.

van Ineveld, B. M., G. J. van Oortmarssen, H. J. de Koning, R. Boer, and P. J. van der Maas. 1993. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 29A (12):1663-1668.

Van Le, L., F. F. Broekhuizen, R. Janzer-Steele, M. Behar, and T. Samter. 1993. Acetic acid visualization of the cervix to detect cervical dysplasia. Obstet Gynecol 81 (2):293-295.

van Oortmarssen, G. J. 1995. Evaluation of mass screening for cancer: a model-based approach [dissertation], Department of Public Health, Erasmus University Rotterdam, Rotterdam.

van Oortmarssen, G. J., J. D.F. Habbema, J.Th.N. Lubbe, and P. J. van der Maas. 1990a. A model-based analysis of the HIP project for breast cancer screening. Int J Cancer 46:207-213.

van Oortmarssen, G. J., J. D.F. Habbema, and M. van Ballegooijen. 1992. Predicting mortality from cervical cancer after negative smear test results [see comments]. BMJ 305:449-451.

van Oortmarssen, G. J., J. D.F. Habbema, P. J. van der Maas, H. J. de Koning, H. J. A. Collette, and et al. 1990b. A model for breast cancer screening. Cancer 66 (7):1601-1612.

Verbeek, A. L. M., R. Holland, F. Sturmans, J.H.C.L. Hendriks, M. Mravunac, and N. E. Day. 1984. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen Project, 1975-1981. Lancet 1 (8388):1222-1224.

Vessey, M. 1994. Breast cancer screening 1991: Evidence and experience since the Forrest Report. Sheffield: Department of Health Advisory Committee, NHS Breast Screening Programme.

Warmerdam, P. G., H.J. de Koning, R. Boer, P. M. M. Beemsterboer, M. L. Dierks, and et al. 1997. Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany. J Epidemiol Community Health 51 (2):180-186.

Weinstein, M. C., J. E. Siegel, M. R. Gold, M. S. Kamlet, and L. B. Russell. 1996. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276 (15):1253-1258.

Weiss, N. S. 1983. Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol 118 (4):457-460.

Weiss, N. S., and D. Lazovich. 1996. Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome. Am J Epidemiol 143 (4):319-322.

Weiss, N. S., B. McKnight, and N. G. Stevens. 1992. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 135 (7):817-823.

Wesley, R., R. Sankaranarayanan, B. Mathew, B. Chandralekha, A. Aysha Beegum, and N. S. Amma. 1997. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 75 (3):436-440.

Whitmore, W. F., Jr., J. A. Warner, and I. M. Thompson, Jr. 1991. Expectant management of localized prostatic cancer. Cancer 67 (4):1091-1096.

Wildhagen, M. 1999. Costs and effects of genetic screening with application to cystic fibrosis and fragile X syndrome [dissertation], Department of Public Health, Erasmus University Rotterdam, Rotterdam.